Regulatory product record
PROZINC
Product identity, ingredients and source provenance from the regulatory catalogue. Linked clinical evidence has a separate review status.
Product identity
- Brand name
- PROZINC
- DIN
- 02405202
- DPD drug code
- 89002
- Regulatory category
- APPROVED_VET_DRUG
- Market status
- MARKETED
- Route(s)
- SUBCUTANEOUS
- Pharmaceutical form(s)
- SUSPENSION
- Ingredients
- INSULIN (HUMAN) (40 UNIT)
- Species (DPD record)
- CATS, DOGS
- Company
- BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. (DIN owner)
Source and provenance
- Source dataset
- health_canada_dpd_marketed
- Source snapshot date
- Not available in this source
- Source record key
- 89002
- Archive fingerprint (SHA-256)
- 85cc3ce208af3aa57018c3d14d83f90220c436baef7455384b6d48d9774e1c88
Linked clinical reference
Clinical entries are linked through the active molecule. Check their species, formulation, source and review status separately from this product record.
Clinical evidence
Dose regimens0
No dose regimens recorded for this species selection.
Adverse effects52
These are counts of spontaneously reported events, not proven adverse effects, causal relationships, or incidence rates.
Bars compare report counts within each species; they do not show incidence.
More reportsFewer reportsDog
- Ataxia3 reports
- Blindness2 reports
- Death2 reports
- Lack of efficacy (bacteria) - Leptospira2 reports
- Seizure NOS2 reports
- Vomiting2 reports
- ABNORMAL TEST RESULT, THYROID NOS1 reports
- Abnormal posture NOS1 reports
- Acute renal failure1 reports
- Anorexia1 reports
- Behavioural disorder NOS1 reports
- Breathing difficulty1 reports
Cat
- Anorexia1 reports
- Death by euthanasia1 reports
- INEFFECTIVE, GLYCEMIC CONTROL1 reports
- Liver failure1 reports
- Renal failure1 reports
- Urinary tract infection1 reports
Literature references17
References are linked to this drug. Species applicability is not recorded here, so the species filter does not narrow this list. Imported dates do not retain their original precision; confirm dates in the original citation.
- Pharmacokinetic barriers to oxfendazole flukicidal efficacy.
Study summary not available in the imported record. Open the original citation to review the study.
- Sixty-day oral antioxidant supplementation enhances sperm morphology and seminal plasma antioxidant capacity in stallions.
Study summary not available in the imported record. Open the original citation to review the study.
- Host-parasite-microbiome interactions in gastrointestinal trematodes and cestodes of small ruminants: current advances and future perspectives.
Study summary not available in the imported record. Open the original citation to review the study.
- Narasin used as a feed additive in conventional rearing of broilers can co-select for vancomycin-resistant Enterococcus faecium through the NarAB ionophore resistance mechanisms.
Study summary not available in the imported record. Open the original citation to review the study.
- Sustained improvements in human-cat interaction in the shelter sector: a study of a best-practice educational intervention.
Study summary not available in the imported record. Open the original citation to review the study.
Sources: PubMed, National Library of Medicine; openFDA, U.S. Food and Drug Administration.